Cisplatin nephrotoxicity: symptomatic hypomagnesemia and renal failure.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  The International journal of pediatric nephrology

• Publication date

  1986-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 3804580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations.

  1985cited by this paper
• Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats.

  1985cited by this paper
• Effect of cisplatin on the transepithelial potential difference of rat distal tubule.

  1985cited by this paper
• High-dose cisplatin in hypertonic saline.

  1984cited by this paper
• Renal and electrolyte disturbances associated with cisplatin.

  1981cited by this paper
• Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.

  1979cited by this paper
• Long term effect of Cis‐Diamminedichloride platinum (CDDP) on renal function and structure in man

  1978cited by this paper

• IGF2BP3/NCBP1 complex inhibits renal tubular senescence through regulation of CDK6 mRNA stability.

  2024cites this paper
• Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy

  2021cites this paper
• Differential effect of NDGA on cisplatin-induced nephrotoxicity in Spargue-Dawley rats

  2019cites this paper
• Probiotic bacteria attenuates cisplatin-induced nephrotoxicity through modulation of oxidative stress, inflammation and apoptosis in rats

  2019cites this paper
• Renoprotective effect of the isoflavonoid biochanin A against cisplatin induced acute kidney injury in mice: Effect on inflammatory burden and p53 apoptosis

  2018cites this paper
• A retrospective evaluation of furosemide and mannitol for prevention of cisplatin‐induced nephrotoxicity

  2017cites this paper
• Investigation of the effect of cornelian cherry (Cornus mas L.) fruit extract against cisplatin-induced renal cell injury in vitro

  2017cites this paper
• STUDY OF THE EFFECT OF DIBENZAZEPINE IN RENAL INJURY INDUCED BY CISPLATIN IN RATS

  2017cites this paper
• A Comprehensive Review on the Genetic Regulation of Cisplatin-induced Nephrotoxicity

  2016cites this paper
• The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not?

  2015cites this paper
• Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.

  2015cites this paper
• Profiles and preventive strategies of nephrotoxicity among adult patients receiving cisplatin based regimens at Kenyatta national hospital

  2014cites this paper
• Mitochondrial dysregulation and protection in cisplatin nephrotoxicity

  2014cites this paper
• Nanocarriers for delivery of platinum anticancer drugs.

  2013cites this paper
• Mild hypomagnesemia as the most common Cisplatin nephropathy in Iran.

  2013cites this paper
• Effect of Oral Administration of Magnesium on Cisplatin-Induced Nephrotoxicity in Normal and Streptozocin-Induced Diabetic Rats

  2013cites this paper
• Nephrotoxicity of platinum derivatives in children – a review of the literature

  2011cites this paper
• Serum potassium, calcium and magnesium in patients receiving ESHAP chemotherapy for relapsed lymphomas

  2009cites this paper
• Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

  2008cites this paper
• Drug-Induced Hypomagnesaemia

  2005cites this paper
• Renal impairment and hypertension in brain tumor patients treated in childhood are mainly associated with cisplatin treatment

  2005cites this paper
• Cisplatin-Induced Nephrotoxicity

  2004cites this paper
• Assessment of chemotherapy-associated nephrotoxicity in children with cancer

  2004cites this paper
• Cytoprotection in the treatment of pediatric cancer: review of current strategies in adults and their application to children.

  1999cites this paper
• Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.

  1999cites this paper
• Trace metals in patients with acute renal failure

  1998cites this paper
• Cumulative toxicities from cisplatin therapy and current cytoprotective measures.

  1998cites this paper
• Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis.

  1997cites this paper
• Cytostatics — induced tubular toxicity

  1993cites this paper
• Chronic renal magnesium loss, hypocalciuria and mild hypokalaemic metabolic alkalosis after cisplatin

  1990cites this paper
• Computer viruses

  1988cites this paper